<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    FibroGen, Inc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About FibroGen, Inc

    FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Thomas B. Neff
    • FOUNDED
      1993
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Hoth Therapeutics, Inc.

    Hoth Therapeutics, Inc.

    Hoth Therapeutics is a development stage biopharmaceutical company focused on prop...

    Hoth Therapeutics is a development stage biopha...

    Filing Type:    PU
    Premier, Inc.

    Premier, Inc.

    Premier operates one of the nation’s largest performance improvement alliances o...

    Premier operates one of the nation’s largest ...

    Filing Type:    PU
    BelleIQ, Inc.

    BelleIQ, Inc.

    BelleIQ operates ALLIES, an online marketplace selling health & wellness products ...

    BelleIQ operates ALLIES, an online marketplace ...

    Amount Raised:    $0
    Fundraising Status:    EC
    Filing Type:    CF
    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the deve...

    Citius Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Entasis Therapeutics Holdings Inc.

    Entasis Therapeutics Holdings Inc.

    Entasis is a clinical-stage biopharmaceutical company focused on the discovery, de...

    Entasis is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Cancer Genetics, Inc.

    Cancer Genetics, Inc.

    Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and se...

    Cancer Genetics, Inc. is an emerging leader in ...

    Filing Type:    PU
    Mersana Therapeutics, Inc.

    Mersana Therapeutics, Inc.

    Mersana Therapeutics is a clinical-stage biopharmaceutical company using its diffe...

    Mersana Therapeutics is a clinical-stage biopha...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    AMAG Pharmaceuticals, Inc.

    AMAG Pharmaceuticals, Inc.

    Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicin...

    Headquartered in Waltham, Massachusetts, we dev...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.